Comparative multi-omics of the macrophage response to infection with Mycobacterium tuberculosis complex bacteria reveals pathogen-driven epigenomic reprogramming
Thomas Jonathan HalliD, Morgane MitermiteiD, John Francis O'GradyiD, John Arthur BrowneiD, Gillian P. McHugoiD, Emily L. ClarkiD, Mazdak SalavatiiD, Stephen Vincent GordoniD, David Evan MacHughiD
Abstract
BackgroundBovine tuberculosis (bTB) is a chronic infectious disease primarily caused by Mycobacterium bovis, which inflicts significant economic losses on the global livestock industry worldwide and can also cause tuberculosis (TB) disease in other mammalian species, including humans. Alveolar macrophages are the host cells targeted by the pathogen during the early stages of infection. While they play a crucial role in controlling infection, the exact nature of the host-pathogen interaction and the genetic and epigenetic factors that modulate infection outcome remain poorly understood. ResultsHere, we used transcriptomics (RNA-seq), chromatin accessibility (ATAC-seq), and chromatin configuration (ChIP-seq) analyses to examine the effects of intracellular mycobacterial infection on the bovine alveolar macrophage (bAM) transcriptome and epigenome. The primary focus was M. bovis infection, but we also conducted parallel comparative analyses using M. tuberculosis (the primary cause of human TB--hTB), M. bovis BCG (the vaccine strain), and gamma-irradiated (killed) M. bovis. Integration of RNA-seq, ChIP-seq, and ATAC-seq data revealed coordinated remodelling of chromatin accessibility and histone modification landscapes underpinning transcriptional activation of key immune and metabolic pathways in response to infection. The identification of candidate genes, including ERBB4, LRCH1, MRTFA, and RNPC3, through integrative analysis with a genome-wide association study (GWAS) for M. bovis infection susceptibility underscores the functional relevance of these regulatory networks. ConclusionsOur results demonstrate that M. bovis drives extensive reprogramming of the bAM epigenome, distinct from the responses elicited by other members of the M. tuberculosis complex (MTBC). The results of this multi-omics comparison provide new insights into the function of pivotal response genes and support the hypothesis that pathogen-driven epigenetic reprogramming of the bovine host macrophage is key to M. bovis survival. It also identifies molecular targets that may inform genome-enabled breeding strategies to enhance resilience to bTB in cattle.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alveolar macrophage chromatin is modified to orchestrate host response to Mycobacterium bovis infection
Thomas Jonathan Hall, Douglas Vernimmen, … Alan Mark O’Doherty·Frontiers in GeneticsPeer-reviewed·Feb 7, 2020
- Integrative genomics of the mammalian alveolar macrophage response to intracellular mycobacteria
Thomas Jonathan Hall, Michael P. Mullen, … David Evan MacHugh·BMC GenomicsPeer-reviewed·May 12, 2021
- Integrative and comparative genomic analyses of mammalian macrophage responses to intracellular mycobacterial pathogens
Thomas Jonathan Hall, Gillian P. McHugo, … David Evan MacHugh·TuberculosisPeer-reviewed·Dec 2, 2023
- Comparative omics analyses differentiate Mycobacterium tuberculosis and Mycobacterium bovis and reveal distinct macrophage responses to infection with the human and bovine tubercle bacilli
Kerri M. Malone, Kévin Rue-Albrecht, … Stephen Vincent Gordon·Microbial GenomicsPeer-reviewed·Mar 1, 2018
- The bovine alveolar macrophage DNA methylome is resilient to infection with Mycobacterium bovis
Alan Mark O’Doherty, Kévin Rue-Albrecht, … David Evan MacHugh·Scientific ReportsPeer-reviewed·Feb 6, 2019
- Epigenetic Crosstalk Between BCG-Infected Macrophages and Naive Monocytes Potentiates Antimycobacterial Activity
Lovisa Ellinger, Shamila D. Alipoor, … Maria Lerm·bioRxiv·Jan 12, 2026